Skip to main content
DEINOVE logo

DEINOVE — Investor Relations & Filings

Ticker · ALDEI ISIN · FR0010879056 LEI · 969500BEJSRFER0F2K08 PA Professional, scientific and technical activities
Open in API
Filings indexed 300 across all filing types
Latest filing 2018-01-30 Regulatory Filings
Country FR France
Listing PA ALDEI

About DEINOVE

https://www.deinove.com

DEINOVE is a biotechnology company that discovers, develops, and produces high-value compounds derived from rare bacteria and microorganisms, often referred to as 'microbial dark matter'. Leveraging a proprietary technology platform, the company harnesses the metabolic potential of extremophilic bacteria, such as Deinococcus, to create innovative solutions. Its primary applications are focused on developing novel bio-based active ingredients, including carotenoids, for the cosmetics sector, and discovering new antibiotics to address the global challenge of antimicrobial resistance.

Recent filings

Filing Released Lang Actions
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Regulatory Filings Classification · 1% confidence The document is explicitly titled "Press release" and details a new partnership between DEINOVE and OLÉOS for developing a cosmetic active ingredient, including quotes from management and company descriptions. This type of announcement, which is not a formal regulatory filing like a 10-K, earnings release (ER), or a specific financial report, typically falls under general corporate communications. Since it is a press release announcing a business development (partnership), and there is no specific category for 'Press Release' or 'Business Development', the most appropriate fallback category is 'Regulatory Filings' (RNS), as it serves as a general announcement to the market that doesn't fit the highly specific financial or governance categories provided. The document length (3769 chars) is substantial enough to be the primary announcement, not just a notification of an attachment.
2018-01-30 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is titled "Communiqué de presse" (Press Release) and details progress in a co-development program between DEINOVE and GREENTECH regarding a cosmetic active ingredient. It announces milestones, next steps (technology transfer, final selection), and expected commercial launch timing. This type of announcement, focusing on operational updates, partnerships, or preliminary results outside of mandated periodic financial filings (like 10-K or IR), typically falls under general regulatory announcements or news releases. Since it is not a formal financial report (10-K, IR, ER), nor a specific corporate action like a dividend (DIV) or management change (MANG), the most appropriate general category for a press release detailing business progress is Regulatory Filings (RNS), which serves as a broad category for non-standard regulatory news.
2017-11-20 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 1% confidence The document is titled as a "Press release" and details progress in a co-development program between DEINOVE and GREENTECH regarding a cosmetic active ingredient. It announces milestones, testing phases, and technology transfer, concluding with contact information and boilerplate company descriptions. This type of announcement, which is not a formal regulatory filing like a 10-K, a specific financial report (ER, IR), or a shareholder vote result, fits best under the general category for corporate news releases that don't fit elsewhere. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general press release announcing business progress, although it is not a formal regulatory filing in the SEC sense. However, since it is a press release announcing business progress and not a specific financial report, and it doesn't fit any other specific category (like M&A, Capital Change, or Earnings Release), RNS serves as the best general announcement category.
2017-11-20 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is titled 'Communiqué de presse' (Press Release) and announces a specific business update: the confirmation of the launch timeline for a cosmetic active ingredient in the first half of 2018. It details product development steps (stability studies, large-scale production planning, clinical tests) and marketing interest. This type of announcement, which communicates key operational and strategic updates outside of mandatory periodic financial filings (like 10-K or IR), is typically classified as a general regulatory announcement or press release. Since it is not a formal Earnings Release (ER), Interim Report (IR), or a specific transaction notice, and it is a direct communication to the market about business progress, it fits best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous official announcements. Given the short length (under 5,000 characters) and the nature of communicating an update rather than providing the full underlying report, RNS is the most appropriate classification.
2017-10-23 French
Communicated under the obligation to provide permanent information / Other communications
Earnings Release Classification · 1% confidence The document is a press release dated October 23, 2017, confirming progress and setting a timeline (H1 2018) for the launch of a new cosmetic active ingredient. It details product development steps (stability studies, large-scale production, in vivo tests) and mentions commercial interest. This type of announcement, focusing on operational progress, product pipeline updates, and future commercialization timelines, is characteristic of an Earnings Release (ER) or a general corporate update. Since it is not a full financial report (10-K or IR), a transcript (CT), or a specific regulatory filing like DIRS or DIV, and it serves as an initial announcement of business progress rather than just a report publication announcement (RPA), ER is the most appropriate fit for key operational updates outside of formal quarterly reporting periods. Given the context of a biotech company updating on product milestones, it functions as an Earnings Release or a significant corporate update. H1 2018
2017-10-23 English
Rapport financier semestriel
Interim / Quarterly Report Classification · 1% confidence The document is a 'Rapport financier semestriel 2017' (Half-Year Financial Report 2017) for Groupe DEINOVE. It contains detailed sections on management, business activities, and consolidated financial statements (balance sheet, income statement, cash flow, etc.) for the period ending June 30, 2017. As it is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data, it is classified as an Interim/Quarterly Report. H1 2017
2017-09-28 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.